Serving the growing biotechnology community

The Latest News from BioAgilytix

3 August, 2020

BioAgilytix Rebrands Its Cambridge Biomedical Diagnostic Testing Division to BioAgilytix Diagnostics

The new name is reflective of BioAgilytix’s plan, which was set forth following its acquisition of Boston-based Cambridge Biomedical in late 2019, to fully integrate Cambridge Biomedical’s clinical and diagnostic testing capabilities into BioAgilytix’s global service offerings.

Read More

1 July, 2020

Analytical Assays Determine Biosimilar Product Quality

BioAgilytix supplies its assay expertise to describe the appropriate analytical assays needed to determine and ensure that biosimilar critical quality parameters are on track.

Read More

30 June, 2020

Chad Briscoe, Ph.D. Joins BioAgilytix Leadership Team as Chief Scientific Officer

In this role, Dr. Briscoe will provide scientific and regulatory oversight to BioAgilytix’s global teams with strategic guidance in line with emerging scientific developments.

Read More

25 June, 2020

BioAgilytix Welcomes Mike Nicholson, Ph.D. to Leadership Team as Vice President, Operations

In this role, Dr. Nicholson will oversee bioanalytical operations and scientific team development across BioAgilytix’s laboratories in both the USA and Europe, with particular focus leading the organization’s Gene and Cell Therapy bioanalytical services.

Read More

6 May, 2020

Frank Horling, Ph.D. Joins BioAgilytix Leadership Team as General Manager, Europe

In this role, Dr. Horling will lead Operations, Finance, HR, and Facilities for BioAgilytix’s European business and its laboratory located in Hamburg, Germany.

Read More

29 April, 2020

BioAgilytix Welcomes Jim McNally, Ph.D. to Leadership Team as Chief Scientific Officer

Dr. McNally brings with him an extensive background in bioanalytical assay development and program leadership working for almost 20 years in the pharmaceutical and biotechnology industry.

Read More

12 December, 2019

BioAgilytix Welcomes Dominic Marasco to Leadership Team as Chief Commercial Officer

Mr. Marasco will provide strategic direction to BioAgilytix’s global business development and marketing functions / teams to further expand worldwide adoption of the company’s premier bioanalytical services.

Read More

27 November, 2019

Immunogenicity Assessment of Gene Therapy Compounds

In an Expert Opinion article published by Contract Pharma, PD Dr. Arno Kromminga of BioAgilytix discusses testing challenges and evolving trends in gene therapy.

Read More

11 November, 2019

Behind the deal: Why a Triangle company is buying its competitor in Cambridge

The Triangle Business Journal covers BioAgilytix’s recent acquisition of Cambridge Biomedical in the Cambridge area of Massachusetts, a known hotbed of biotech innovation.

Read More